Diuretic use in stage 5 chronic kidney disease and end-stage renal disease

Curr Opin Nephrol Hypertens. 2003 Sep;12(5):483-90. doi: 10.1097/00041552-200309000-00001.
No abstract available

Publication types

  • Editorial
  • Review

MeSH terms

  • Benzothiadiazines
  • Diuretics / adverse effects
  • Diuretics / pharmacokinetics
  • Diuretics / therapeutic use*
  • Half-Life
  • Humans
  • Hypertension, Renovascular / etiology
  • Kidney Failure, Chronic / drug therapy*
  • Sodium Chloride Symporter Inhibitors / therapeutic use

Substances

  • Benzothiadiazines
  • Diuretics
  • Sodium Chloride Symporter Inhibitors